ZA852316B - Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders - Google Patents

Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders

Info

Publication number
ZA852316B
ZA852316B ZA852316A ZA852316A ZA852316B ZA 852316 B ZA852316 B ZA 852316B ZA 852316 A ZA852316 A ZA 852316A ZA 852316 A ZA852316 A ZA 852316A ZA 852316 B ZA852316 B ZA 852316B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
treatment
pharmaceutical composition
cardiac disorders
cardiac
Prior art date
Application number
ZA852316A
Other languages
English (en)
Inventor
Agustin Escobar
Dietmar M Wagenknecht
Ahmad Waseem Malick
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of ZA852316B publication Critical patent/ZA852316B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L65/00—Network arrangements, protocols or services for supporting real-time applications in data packet communication
    • H04L65/1066—Session management
    • H04L65/1083—In-session procedures
    • H04L65/1095—Inter-network session transfer or sharing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Business, Economics & Management (AREA)
  • Multimedia (AREA)
  • Neurosurgery (AREA)
  • General Business, Economics & Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA852316A 1984-04-09 1985-03-27 Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders ZA852316B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59806184A 1984-04-09 1984-04-09

Publications (1)

Publication Number Publication Date
ZA852316B true ZA852316B (en) 1985-11-27

Family

ID=24394068

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852316A ZA852316B (en) 1984-04-09 1985-03-27 Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders

Country Status (9)

Country Link
US (1) US5017609A (de)
EP (1) EP0179808B1 (de)
JP (1) JPH0720861B2 (de)
AU (1) AU575153B2 (de)
CA (1) CA1242395A (de)
DE (1) DE3584560D1 (de)
IT (1) IT1184271B (de)
WO (1) WO1985004580A1 (de)
ZA (1) ZA852316B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000509B (el) * 1988-06-08 1992-07-30 Du Pont Μεθοδος παρασκευης σταθερης ενεσιμης υδατικης συνθεσεως υδροχλωρικου 3-[4-(2-υδροξυ-3-ισοπροπυλαμινο) προποξυ]-φαινυλοπροπιονικου μεθυλεστερα.
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
TWI277414B (en) * 2001-01-12 2007-04-01 Baxter Int Esmolol formulation
US6310094B1 (en) * 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
MXPA04002446A (es) * 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
ES2383994T3 (es) * 2004-04-07 2012-06-28 Ares Trading S.A. Formulación líquida de hormona del crecimiento
PL1773307T3 (pl) * 2004-07-30 2015-03-31 Novartis Ag Preparaty 2-amino-1,3-propanodioli i ich analogów
JP2008543842A (ja) * 2005-06-14 2008-12-04 バクスター インターナショナル インコーポレイテッド 薬物−薬物相互作用を最小にするための薬学的処方物
AU2006315177A1 (en) * 2005-11-15 2007-05-24 Baxter Healthcare S.A. Compositions of lipoxygenase inhibitors
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
AU2014203121B2 (en) * 2007-05-22 2016-04-21 Baxter Healthcare Sa Concentrate esmolol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
ES2397126T3 (es) * 2007-12-21 2013-03-04 Aop Orphan Pharmaceuticals Ag Composición farmacéutica para la administración parenteral de un antagonista del receptor beta-adrenérgico de acción ultrarrápida
WO2011039780A2 (en) 2009-09-22 2011-04-07 Vlife Sciences Technologies Pvt. Ltd. Topical formulation for diabetic foot ulcers
AU2012211318C1 (en) 2011-01-27 2016-08-04 Baxter Healthcare S.A. Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension
CN103347513A (zh) 2011-01-27 2013-10-09 巴克斯特国际公司 (s)-艾司洛尔用于控制与心脏病治疗相关的静脉刺激的应用
CN104473869A (zh) * 2014-11-20 2015-04-01 北京京科泰来科技有限公司 一种艾司洛尔脂肪乳及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
DE1643262C3 (de) * 1967-12-13 1975-06-26 C.H. Boehringer Sohn, 6507 Ingelheim i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3015991A1 (de) * 1980-04-25 1981-11-05 C.H. Boehringer Sohn, 6507 Ingelheim Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zur ihrer herstellung
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents

Also Published As

Publication number Publication date
IT1184271B (it) 1987-10-22
CA1242395A (en) 1988-09-27
JPS61501775A (ja) 1986-08-21
EP0179808B1 (de) 1991-10-30
AU575153B2 (en) 1988-07-21
US5017609A (en) 1991-05-21
EP0179808A4 (de) 1987-10-27
EP0179808A1 (de) 1986-05-07
AU4150785A (en) 1985-11-01
WO1985004580A1 (en) 1985-10-24
JPH0720861B2 (ja) 1995-03-08
DE3584560D1 (de) 1991-12-05
IT8547927A0 (it) 1985-04-05

Similar Documents

Publication Publication Date Title
IL83925A0 (en) Compositions for treatment of skin disorders
DE3574228D1 (en) Rate scanning demand pacemaker and method for treatment of tachycardia
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
SG96694G (en) Treatment of skin disorders
EG16108A (en) Method for treatment or prophylaxis of cardiac disorders
EP0179808A4 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstörungen.
ZA857081B (en) Composition for the treatment of allergy
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
PH18954A (en) Method for treatment or prophylaxis of cardiac disorders
AU7896781A (en) Method for treatment or prophylaxis of cardiac disorders
AU2387988A (en) Method of treating skin disorders
ZA845271B (en) Pharmaceutical and veterinary compositions for the treatment of ischemic cardiac disorders
GB8428747D0 (en) Products for treatment of human body
AU591107B2 (en) Psoralene-based bath compositions for treatment of skin disorders
ZA817931B (en) Compounds and method for treatment or prophylaxis of cardiac disorders
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
GB2170403B (en) Medicament for treatment of asthma and preparation thereof
GB8715914D0 (en) Treatment of cerabral disorders
GB2205743B (en) Cosmetic method and composition for prevention and/or treatment of dandruff
ZA855613B (en) Composition and method for the treatment of hemorrhoids
DE3173674D1 (en) Compounds and method for treatment or prophylaxis of cardiac disorders
ZA881828B (en) Preparation for treatment of skin disorders
ZA888338B (en) Pharmaceutical compositions and method of treatment
GB8311803D0 (en) Treatment of seizure disorders and pharmaceutical compositions
IE842027L (en) Treatment of skin disorders